JP Morgan Put 380 GS 21.06.2024/ DE000JB7VHE5 /
2024-06-05 12:29:54 PM | Chg.0.000 | Bid12:35:12 PM | Ask12:35:12 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.001 Bid Size: 7,500 |
0.011 Ask Size: 7,500 |
Goldman Sachs Group ... | 380.00 USD | 2024-06-21 | Put |
GlobeNewswire
2:00 PM
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
1:30 PM
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:00 PM
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
1:00 PM
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare C...
GlobeNewswire
1:00 PM
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:00 PM
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:00 PM
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05-09
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04-11
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties